Does Ozempic Cause Weight Loss by Impacting the Brain or the Gut?
A study from The Netherlands examines the impacts of GLP-1 agonists on the central nervous system using fMRI.
Is Ozempic the Gateway Drug for CBT?
Two recent studies show nearly twice the weight loss for patients who undergo group CBT in addition to taking liraglutide, a GLP-1 agonist.
Ozempic Maker to Study Its Effect on Alcohol Consumption
Novo Nordisk, the maker of Ozempic, plans to study the drug’s effect on alcohol consumption.
GLP-1 Drugs Used to Reduce Cancer, Fight Dementia
GLP-1 agonists such as Ozempic and Wegovy are being tested for their ability to impact cancer rates and slow dementia.
More Studies Show Positive Impacts From GLP-1 Agonist Drugs
A new survey from National Geographic explores many positive outcomes of recent trials with GLP-1 agonist drugs.
Drug Companies “Apathetic” About Testing GLP-1 Drugs to Treat Substance Use Disorders
Early studies of GLP-1 drugs for substance abuse treatment show promise, but drug companies are slow to fund research.